CT
BIO icon

Chicago Trust’s Bio-Rad Laboratories Class A BIO Stock Holding History

Chicago Trust’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,299
Closed -$213K – 157
2016
Q3 		$213K Sell
1,299
-519
-29% -$78.8K 0.09% 141
2016
Q2 		$260K Hold
1,818
– – 0.11% 131
2016
Q1 		$249K Buy
+1,818
New +$239K 0.1% 131
2015
Q2 		– Sell
-2,395
Closed -$324K – 180
2015
Q1 		$324K Buy
+2,395
New +$297K 0.11% 141

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

Chicago Trust's BIO Position: Q4 2016 in Review

Chicago Trust sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2016, closing a stake of 1,299 shares — an estimated $213K sold.

Chicago Trust first reported a position in BIO in Q1 2015 and held it in 4 quarters. The position peaked at $324K in Q1 2015. 261 funds tracked by Wall St. Rank hold BIO as of Q4 2016.

  • Chicago Trust reported no remaining Bio-Rad Laboratories Class A position as of Q4 2016 after selling out during the quarter.
  • Chicago Trust sold 1,299 Bio-Rad Laboratories Class A shares in Q4 2016, an estimated $213K.
  • Chicago Trust first reported a position in Bio-Rad Laboratories Class A in Q1 2015 and held it in 4 quarters.
  • Chicago Trust's Bio-Rad Laboratories Class A position peaked at $324K in Q1 2015.
  • 261 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2016.

Based on Chicago Trust's 13F filing for Q4 2016, filed 18 Jan 2017.